Atherosclerosis Cerebrovascular disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Age >18 years - Stroke or TIA with signs or ischemia on imaging compatible with the neurological deficit. - Scheduled for carotid endarterectomy based on current clinical standards
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Severe disability (stay in nursing home). - Auto-immune or auto-inflammatory disease - Current use of immunomodulating drugs - Recent infection with fever >38.5 C
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Markers of macrophage proliferation and activation in the explanted carotid plaque. 2. Markers of proliferation of the HSPCs and the composition and phenotype of the HSPCs in the bone marrow aspirate 3. Number and phenotype of circulating myeloid cells. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. 18F-FDG uptake in the culprit carotid artery (ie the carotid artery that corresponds with the neurological symptoms of the TIA or stroke and will be operated) and the other large arteries (including aorta, carotid arteries, iliac arteries) 2. 18F-FDG uptake in the bone marrow | — |
Countries
Netherlands